Moreover, the lowered expression of BCL2, typically involved in inhibiting cell death, hints at a subtle susceptibility of ESCC cells to apoptotic triggers, an aspect critical to understanding the survival strategies of ESCC cells. The gene discussed is BCL2; the disease is esophageal squamous cell carcinoma.